English  |  正體中文  |  简体中文  |  2816861  
???header.visitor??? :  27619792    ???header.onlineuser??? :  571
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"lee k d"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 24  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-08-19T00:20:58Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma Shao Y.-Y.; Lin Z.-Z.; CHIUN HSU; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2022-08-12T06:27:35Z EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid Yeh D.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Wang H.-C.; Rau K.-M.; Feng Y.-H.; Chang Y.-C.; Lee K.-D.; Ou-Yang F.; Kuo W.-H.; KING-JEN CHANG; Lin Y.-C.; Tseng L.-M.; Hou M.-F.
臺大學術典藏 2022-06-10T06:11:09Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2022-03-31T02:38:47Z Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells Wu C.-Y.; Cherng J.-Y.; Yang Y.-H.; Lin C.-L.; Kuan F.-C.; Lin Y.-Y.; Lin Y.-S.; Shu L.-H.; Cheng Y.-C.; Liu H.T.; Lu M.-C.; Lung J.; PAU-CHUNG CHEN; Lin H.K.; Lee K.-D.; Tsai Y.-H.
臺大學術典藏 2022-03-31T02:38:42Z The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma Huang C.-E.; Yang Y.-H.; Chen Y.-Y.; Chang J.-J.; Chen K.-J.; Lu C.-H.; Lee K.-D.; PAU-CHUNG CHEN; Chen C.-C.
臺大學術典藏 2021-09-01T01:54:02Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-11T03:46:47Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-05-07T06:02:21Z Status for clinically complete remission rectal cancer after concomitant chemo-radiotherapy in Taiwan Lin G.-P.; Lee K.-D.; Wang J.-Y.; Chen J.-S.; CHUN-JU CHIANG; Yeh C.-Y.
臺大學術典藏 2021-01-28T01:06:31Z Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: A multicenter prospective Phase II trial Hsieh J.C.; Hsu C.-L.; Ng S.-H.; Wang C.-H.; Lee K.-D.; Lu C.-H.; Chang Y.-F.; Hsieh R.-K.; KUN-HUEI YEH; Hsiao C.-H.; Chen S.-Y.; Shiau C.-Y.; Wang H.-M.
臺大學術典藏 2020-05-25T06:51:58Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma Cheng A.-L.;Hsu C.-H;Shen Y.-C;Huang C.-C;Yen-Shen Lu;Hsiao C.-H;Lee K.-D;Hsu C;Lin Z.-Z;Shao Y.-Y; Shao Y.-Y; Lin Z.-Z; Hsu C; Lee K.-D; Hsiao C.-H; YEN-SHEN LU; Huang C.-C; Shen Y.-C; Hsu C.-H; Cheng A.-L.

Showing items 1-10 of 24  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page